TrialBlood2022
Clonal hematopoiesis, myeloid disorders and BAX-mutated myelopoiesis in patients receiving venetoclax for CLL.
Piers Blombery et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
50 papers cite it
this papercites it
TrialBlood2022
Piers Blombery et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.